Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Regarding the PPS
5
May 16, 2008 02:41PM
4
May 16, 2008 03:12PM

OK,The company buys 50 mil shares at 30 cents which won't be the average price because the price rises with this kind of buying.....and they spend 15 mil+ in the process. Now they have 340 mil shares out there and no cash.....what would you project the price to be? It is too big a hurdle to effectively reduce shares and maintain PPS, given the current earnings scenario. imo

Now, if the circumstances surrounding PTSC's current cash flow were to be given a major infusion.....then maybe they could support buyback and company plans at the same time. I suggest that any recent buying has only been done to counter Swartz selling......support for the share price as we get rid of the real downside pressure. Once Swartz is out of the way.....Ptsc will cease buying. Ther is no future in it unless they had the capital to reduce it by at least 100 mil shares and then some.

3
May 16, 2008 09:26PM
Share
New Message
Please login to post a reply